Immunitybio Inc (IBRX)

SBC to Revenue

16.62%

Quarterly · Period ending:

IBRX logo

IBRX SBC to Revenue

Latest reported16.62%
IBRX Quarterly SBC/Revenue (0.00% → 16.62%)
High-resolution chart · PNG

IBRX sbc to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Immunitybio Inc SBC to Revenue — Quarterly
Period endingSBC to Revenue
16.6237%
18.4794%
22.8445%
27.691%
36.5109%
57.7405%
119.6769%
122.6499%
920.6304%
20,665%
9,189.9281%
17,620.7317%
26,980.4878%
3,021.6667%
12,808.2192%
9,008.4746%
29,071.4286%
71,600%
2,610.2564%
20,969.697%
5,269.3215%
11,005.7554%
3,195.2381%
472.8477%
73.8532%
290.9091%
0%
2,308.3333%
3,070.5882%
27,020%
20,100%
12,800%
223,350%
181,460%
74,033.3333%
108,925%
67,007.1429%
91,072.7273%
80,471.4286%
155,575%
194,850%
342,250%
503,957.1429%
361,030%
87,957.1429%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.